Atlas Trials

Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis

Clinical trial NCT00224393 · COMPLETED

Trial details

NCT number
NCT00224393
Sponsor
The Cleveland Clinic
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Primary Systemic Amyloidosis
Start date
2001-02-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.